The Prospects for an IP Waiver Under the TRIPS Agreement
Going forward, practical solutions should focus on scaling up manufacturing and supply, and improving access and affordability.
patent
-
Read more: The Prospects for an IP Waiver Under the TRIPS Agreement -
Read more: The Patent Trial and Appeal Board Again Survives Supreme Court Review The Patent Trial and Appeal Board Again Survives Supreme Court Review
For the generic drug and biosimilar industries, the Supreme Court’s recent decision in United States v. Arthrex, Inc. comes as a relief.
-
Read more: US Support for a WTO Waiver of COVID-19 Intellectual Property – What Does it Mean? US Support for a WTO Waiver of COVID-19 Intellectual Property – What Does it Mean?
An explanation of the WTO waiver of COVID-19 intellectual property, what the U.S. declaration of support means, and likely effects of the waiver.
-
Read more: The COVID-19 Vaccine Patent Waiver: The Wrong Tool for the Right Goal The COVID-19 Vaccine Patent Waiver: The Wrong Tool for the Right Goal
Should a waiver be issued, there is no legal mechanism that can compel the transfer of certain types of know-how or trade secrets.
-
Read more: The Patent Trial and Appeal Board Returns to the Supreme Court The Patent Trial and Appeal Board Returns to the Supreme Court
How the Court decides United States v. Arthrex will have important implications for patent law and for administrative law more generally.
-
Read more: Clash of Titans? A Brewing Dispute between Telehealth Giants Clash of Titans? A Brewing Dispute between Telehealth Giants
Competition between telehealth providers spilled into open conflict last month, as incumbent Teladoc filed a patent infringement suit against Amwell.
-
Read more: Compulsory Licensing for Pharmaceuticals in the EU: A Reality Check Compulsory Licensing for Pharmaceuticals in the EU: A Reality Check
To secure widespread access to a COVID-19 vaccine, many countries plan to seek refuge in a long-existing strategy: compulsory licensing.
-
Read more: Deconstructing Moderna’s COVID-19 Patent Pledge Deconstructing Moderna’s COVID-19 Patent Pledge
In the high-stakes market for COVID-19 vaccines, it is worth considering what motivates a private firm to relinquish valuable IP rights.
-
Read more: Patent Fakes: How Fraudulent Inventions Threaten Public Health, Innovation, and the Economy Patent Fakes: How Fraudulent Inventions Threaten Public Health, Innovation, and the Economy
What if you have a great idea for a new technology, but never actually create it, test it, or determine that it works? Is that patentable?
-
Read more: USMCA Agreement and the Remedies for Patent Infringement USMCA Agreement and the Remedies for Patent Infringement
There are several issues with the proposed U.S.-Mexico-Canada trade agreement on drug pricing, including that it both will lock in bad features of current laws, and is inconsistent with U.S. law.
